Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON.

Suppr

超能文献

作者信息

Räber Lorenz, Windecker Stephan

出版信息

Circulation. 2011 Apr 26;123(16):1709-12. doi: 10.1161/CIRCULATIONAHA.111.023366. Epub 2011 Apr 11.

DOI:10.1161/CIRCULATIONAHA.111.023366

PMID:21482962

Abstract

摘要

相似文献

Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON.

Circulation. 2011 Apr 26;123(16):1709-12. doi: 10.1161/CIRCULATIONAHA.111.023366. Epub 2011 Apr 11.

Stent thrombosis: nightmare of the interventional cardiology era.

Int J Cardiol. 2011 May 5;148(3):e51-2. doi: 10.1016/j.ijcard.2009.03.002. Epub 2009 Mar 12.

Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):201. doi: 10.1002/ccd.22952.

[Comment to article Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis].

Kardiol Pol. 2010 Jun;68(6):646-7.

[Fighting restenosis - never-ending story].

Kardiol Pol. 2010 Sep;68(9):994-5.

Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents.

EuroIntervention. 2011 Mar;6(8):1003-10. doi: 10.4244/EIJV6I8A173.

Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.

J Invasive Cardiol. 2010 Jul;22(7):312-6.

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.

N Engl J Med. 2009 May 7;360(19):1946-59. doi: 10.1056/NEJMoa0810116.

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

N Engl J Med. 2007 Mar 8;356(10):1030-9. doi: 10.1056/NEJMoa067484. Epub 2007 Feb 12.

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.

Am Heart J. 2004 May;147(5):815-22. doi: 10.1016/j.ahj.2003.11.025.

引用本文的文献

Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.

Medicine (Baltimore). 2018 May;97(21):e10850. doi: 10.1097/MD.0000000000010850.

Management of acute coronary syndromes in a developing country; time for a paradigm shift? an observational study.

BMC Cardiovasc Disord. 2015 Oct 24;15:133. doi: 10.1186/s12872-015-0125-y.

Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction.

J Saudi Heart Assoc. 2015 Apr;27(2):85-90. doi: 10.1016/j.jsha.2014.12.002. Epub 2014 Dec 18.

Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register.

Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):56-66. doi: 10.1177/2048872613514013. Epub 2013 Nov 21.

Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial.

Heart Vessels. 2013 Jul;28(4):424-33. doi: 10.1007/s00380-012-0276-z. Epub 2012 Sep 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验